About the Author

Michael Crabtree, ND is General Manager, Science & Innovation Lead at Bioenergy Life Science (BLS) and Valen Labs, where he integrates advanced bioenergetic science with manufacturing execution, regulatory strategy, and digital commercialization. He co-developed and clinically validated RiaGev®, demonstrating increased NAD⁺ metabolome, glutathione production, reduced cortisol, and improved sleep parameters in randomized controlled human trials.

With nearly 14 years at Bioenergy Life Science, Michael has led mechanistic research linking D-ribose to AMPk activation and mitochondrial biogenesis, built integrated science-to-e-commerce pipelines, and positioned BLS as a leader in applied metabolic and mitochondrial science. His broader interests include anti-aging biology, cellular senescence, metabolic adaptability, and the geopolitical forces shaping biotechnology markets.

Areas of Expertise

Credentials & Background

• Doctor of Naturopathic Medicine (ND) National University of Health Sciences · Naturopathic Medicine/Naturopathy · 2014–2018
• General Manager, Science & Innovation Lead Bioenergy Life Science & Valen Labs · Jan 2026–Present · Co-developer of clinically validated RiaGev®
• Director of Scientific Affairs & Product Development Bioenergy Life Science · 7+ years · Intellectual property, functional foods, clinical research & formulation
• Visiting Volunteer Researcher — University of Minnesota Jan 2020–May 2021 · Research: The Role of D-Ribose in AMPk Purinergic Signalling Pathway
• BS, General Science & Premedical Northern State University · 2009–2011
• Philosophy — Millerman School of Political Philosophy Jan 2021–Dec 2023 · Political theory, geopolitics, philosophy of science and technology